Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$4.64 - $9.56 $73,103 - $150,617
-15,755 Reduced 53.17%
13,879 $90,000
Q3 2023

Nov 06, 2023

BUY
$9.4 - $14.04 $30,409 - $45,419
3,235 Added 12.25%
29,634 $279,000
Q2 2023

Jul 27, 2023

BUY
$12.96 - $20.93 $2,177 - $3,516
168 Added 0.64%
26,399 $368,000
Q1 2023

May 02, 2023

SELL
$13.48 - $18.79 $205,340 - $286,228
-15,233 Reduced 36.74%
26,231 $492,000
Q4 2022

Feb 10, 2023

BUY
$12.61 - $18.74 $63,630 - $94,562
5,046 Added 13.86%
41,464 $570,000
Q4 2022

Feb 09, 2023

BUY
$12.61 - $18.74 $193,096 - $286,965
15,313 Added 72.56%
36,418 $501,000
Q3 2022

Nov 02, 2022

SELL
$15.33 - $20.36 $140,330 - $186,375
-9,154 Reduced 30.25%
21,105 $404,000
Q2 2022

Aug 01, 2022

SELL
$11.63 - $21.55 $118,649 - $219,853
-10,202 Reduced 25.21%
30,259 $462,000
Q1 2022

May 04, 2022

BUY
$16.63 - $27.73 $140,473 - $234,235
8,447 Added 26.39%
40,461 $545,000
Q4 2021

Feb 07, 2022

SELL
$20.7 - $34.18 $33,409 - $55,166
-1,614 Reduced 4.8%
32,014 $934,000
Q3 2021

Nov 02, 2021

BUY
$19.05 - $28.32 $274,110 - $407,496
14,389 Added 74.79%
33,628 $725,000
Q2 2021

Aug 03, 2021

BUY
$18.93 - $25.65 $364,194 - $493,480
19,239 New
19,239 $493,000
Q3 2020

Nov 09, 2020

SELL
$6.53 - $8.6 $188,717 - $248,540
-28,900 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$4.11 - $6.78 $83,885 - $138,379
20,410 Added 240.4%
28,900 $190,000
Q1 2020

May 04, 2020

SELL
$3.15 - $7.39 $557 - $1,308
-177 Reduced 2.04%
8,490 $43,000
Q4 2019

Feb 04, 2020

SELL
$5.01 - $8.16 $1,092 - $1,778
-218 Reduced 2.45%
8,667 $57,000
Q3 2019

Nov 12, 2019

BUY
$5.07 - $7.08 $45,046 - $62,905
8,885 New
8,885 $47,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $770M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.